119th Congress · introduced in the House · Feb 7, 2025
Diagnostics Testing Preparedness Plan Act of 2025
Official title from Congress.gov
Latest action (Feb 7, 2025): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Introduced in House (Feb 7, 2025)
Diagnostics Testing Preparedness Plan Act of 2025
This bill requires the Department of Health and Human Services (HHS) to develop and publish a plan for the rapid development and distribution of diagnostic tests in response to a chemical, biological, radiological, or nuclear threat, including an emerging infectious disease, that causes or has significant potential to cause a declared public health emergency.
Specifically, HHS must coordinate with any relevant public and private entities, such as government entities and device manufacturers, in creating the plan and facilitating its collaborative implementation. The plan must take into consideration certain factors specified in the bill, including domestic testing capacity, novel technologies, and medical supply needs. HHS must publish the plan within one year after enactment of the bill and then update the plan every three years.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
Emergency planning and evacuation · Infectious and parasitic diseases · Intergovernmental relations · Manufacturing · Medical tests and diagnostic methods · Public contracts and procurement · Research and development
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
14 citations.
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Health Issues
$90,000
Spent on own lobbying
(HCR) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Brea…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Medical/Disease Research/Clinical Labs
$90,000
Spent on own lobbying
(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Brea…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 15, 2026 · issue area: Health Issues
$90,000
Spent on own lobbying
(HCR) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Brea…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 15, 2026 · issue area: Medical/Disease Research/Clinical Labs
$90,000
Spent on own lobbying
(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Brea…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 15, 2026 · issue area: Health Issues
$160,000
Spent on own lobbying
(HCR) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzh…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 15, 2026 · issue area: Medical/Disease Research/Clinical Labs
$160,000
Spent on own lobbying
(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzh…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 15, 2026 · issue area: Health Issues
$90,000
Spent on own lobbying
(HCR) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzh…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 15, 2026 · issue area: Medical/Disease Research/Clinical Labs
$90,000
Spent on own lobbying
(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzh…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 19, 2025 · issue area: Health Issues
$90,000
Spent on own lobbying
(HCR) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzh…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 19, 2025 · issue area: Medical/Disease Research/Clinical Labs
$90,000
Spent on own lobbying
(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzh…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 14, 2025 · issue area: Health Issues
$100,000
Spent on own lobbying
(HCR) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzh…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 14, 2025 · issue area: Medical/Disease Research/Clinical Labs
$100,000
Spent on own lobbying
(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzh…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 16, 2025 · issue area: Health Issues
$130,000
Spent on own lobbying
(HCR) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES · lobbying firm or registrant: F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 16, 2025 · issue area: Medical/Disease Research/Clinical Labs
$130,000
Spent on own lobbying
(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Clinical Lab Fee Schedule reform and Medicare coverage of F…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing